Ali Yagiz Ayla

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Disease Activity

Rheumatoid Arthritis Patients

Top Venues

Archives of rheumatology

International journal of rheumatic diseases

Rheumatology (Oxford, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Tumay Ak, Leyla Mustafayeva, Ali Yagiz Ayla, Yeliz Celik, Gunay Can, Serdal Uğurlu
Secukinumab after first-line tumor necrosis factor-alpha inhibitor therapy in psoriatic arthritis: A real-world retrospective cohort study. Archives of rheumatology 39 (1) (2024)
Tumay Ak, Leyla Mustafayeva, Ali Yagiz Ayla, Yeliz Celik, Gunay Can, Serdal Uğurlu
Secukinumab after first-line tumor necrosis factor-alpha inhibitor therapy in psoriatic arthritis: A real-world retrospective cohort study. Archives of rheumatology 39 (1) (2024)
Mert Öztaş, Izzet Altun, Ali Yagiz Ayla, Emir Cerme, Çetin Demirdağ, Sertaç Asa, Kerim Sonmezoglu, Serdal Uğurlu
Rituximab in the management of retroperitoneal fibrosis: A single tertiary rheumatology care center experience. International journal of rheumatic diseases (2023)
Tumay Ak, Sera Nur Yucesoy Temiz, Meliksah Taner, Ali Yagiz Ayla, Ahmet Atıl Aygun, Burhan Engin, Gunay Can, Serdal Uğurlu
Effectiveness of anti-interleukin-23 therapy in psoriatic arthritis: A pilot prospective real-world study. International journal of rheumatic diseases (2023)
Serdal Uğurlu, Ruveyda Akcin, Ali Yagiz Ayla, Bekir Kocazeybek, Mert Öztaş, Gunay Can, Leyla Mustafayeva, Nese Saltoglu, Betul Yilmaz, Huri Ozdogan
Antibody responses to inactivated and mRNA SARS-CoV-2 vaccines in familial Mediterranean fever patients treated with interleukin-1 inhibitors. Rheumatology (Oxford, England) 61 (SI2) (2022)